Detalhe da pesquisa
1.
Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor.
Eur J Nucl Med Mol Imaging
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38570359
2.
Development of probes for radiotheranostics with albumin binding moiety to increase the therapeutic effects of astatine-211 (211At).
Eur J Nucl Med Mol Imaging
; 51(2): 412-421, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37819452
3.
Development and evaluation of a theranostic probe with RGD peptide introduced platinum complex to enable tumor-specific accumulation.
Bioorg Med Chem
; 70: 116919, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35816895
4.
68Ga- and 211At-Labeled RGD Peptides for Radiotheranostics with Multiradionuclides.
Mol Pharm
; 18(9): 3553-3562, 2021 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34403257
5.
Synthesis and Evaluation of a Dimeric RGD Peptide as a Preliminary Study for Radiotheranostics with Radiohalogens.
Molecules
; 26(20)2021 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34684688
6.
Astatine-211-labeled aza-vesamicol derivatives as sigma receptor ligands for targeted alpha therapy.
Nucl Med Biol
; 122-123: 108369, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37516066